...
首页> 外文期刊>Journal of Veterinary Pharmacology and Therapeutics >Distribution of ceftiofur into Mannheimia haemolytica-infected tissue chambers and lung after subcutaneous administration of ceftiofur crystalline free acid sterile suspension
【24h】

Distribution of ceftiofur into Mannheimia haemolytica-infected tissue chambers and lung after subcutaneous administration of ceftiofur crystalline free acid sterile suspension

机译:皮下注射头孢噻呋结晶游离酸无菌混悬液后,头孢噻呋在溶血曼海姆氏菌感染的组织腔和肺中的分布

获取原文
获取原文并翻译 | 示例
           

摘要

Washburn, K., Johnson, R., Clarke, C, Anderson, K. Distribution of ceftiofur into Mannheimia haemolytica-infected tissue chambers and lung after subcutaneous administration of ceftiofur crystalline free acid sterile suspension. J. vet. Pharmacol. Therap.33, 141-146. The objective of this study was to evaluate the penetration of ceftiofur- and desfuroylceftiofur-related metabolites (DCA) into sterile and infected tissue chambers, lung tissue and disposition of DCA in plasma across four different sacrifice days postdosing. Twelve healthy calves were utilized following implantation with tissue chambers in the paralumbar fossa. Tissue chambers in each calf were randomly inoculated with either Mannheimia haemolytica or sterile PBS. All calves were dosed with ceftiofur crystalline free acid sterile suspension (CCFA-SS) subcutaneously in the ear pinna. Calves were randomly assigned to 4 groups of 3 to be sacrificed on days 3, 5, 7 and 9 postdosing. Prior to euthanasia, plasma and tissue chamber fluid were collected, and immediately following euthanasia, lung tissue samples were obtained from four different anatomical sites DCA concentration analysis. Results of our study found that, in general, DCA concentrations followed a rank order of plasma > infected tissue chamber fluid > noninfected tissue chamber fluid > lung tissue. Data also indicated DCA concentrations remained above the therapeutic threshold of 0.2 og/mL for plasma and chamber fluid and 0.2 og/g for lung tissue for at least 7 days post-treatment.
机译:Washburn,K.,Johnson,R.,Clarke,C,Anderson,K.皮下注射头孢噻呋结晶游离酸无菌混悬液后,头孢噻呋分配到溶血曼海姆氏菌感染的组织室和肺中。 J.兽医Pharmacol。 Therap.33,141-146。这项研究的目的是评估在给药后四个不同的牺牲天中头孢噻呋和与糠酰头孢噻呋相关的代谢物(DCA)进入无菌和感染的组织腔,肺组织和DCA在血浆中的渗透。在腰旁副窝内植入组织腔后,使用了十二只健康的小牛。将每只小牛的组织室随机接种溶血曼海姆氏菌或无菌PBS。在耳廓皮下给所有小牛皮下注射头孢噻呋结晶游离酸无菌混悬液(CCFA-SS)。将小牛随机分为4组,每组3只,在给药后第3、5、7和9天处死。在安乐死之前,收集血浆和组织腔液,并在安乐死之后立即从四个不同的解剖部位DCA浓度分析中获得肺组织样品。我们的研究结果发现,一般而言,DCA浓度遵循血浆>感染的组织腔积液>未感染的组织腔积液>肺组织的等级顺序。数据还表明,在治疗后至少7天,血浆和腔室液的DCA浓度仍高于0.2 og / mL的治疗阈值,而肺组织的DCA浓度仍高于0.2 og / g的治疗阈值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号